Cargando…
Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies
BACKGROUND: Renal cell carcinoma (RCC) associated with Xp11.2 translocation/TFE3 gene fusion (Xp11.2 RCC) is a rare subtype of RCC which is firstly described as a distinct entity in 2004 so that clinical characteristics of Xp11.2 RCC in different gender and age are unknown. The purpose of systematic...
Autores principales: | Cheng, Xiangming, Gan, Weidong, Zhang, Gutian, Li, Xiaogong, Guo, Hongqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940698/ https://www.ncbi.nlm.nih.gov/pubmed/27401463 http://dx.doi.org/10.1186/s12894-016-0154-6 |
Ejemplares similares
-
Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion
por: Wang, Zhen, et al.
Publicado: (2017) -
Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas
por: He, Jian, et al.
Publicado: (2015) -
Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis
por: Liu, Ning, et al.
Publicado: (2016) -
A new risk-scoring system to predict Xp11.2 translocation renal cell carcinoma in adults
por: Shi, Qiancheng, et al.
Publicado: (2021) -
Are tumor-associated micro-angiogenesis and lymphangiogenesis considered as the novel prognostic factors for patients with Xp11.2 translocation renal cell carcinoma?
por: Ma, Wenliang, et al.
Publicado: (2020)